Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
2
50%
Ph phase_2
2
50%

Phase Distribution

0

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
2(50.0%)
Phase 3Large-scale testing
2(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(3)

Detailed Status

Completed3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 22 (50.0%)
Phase 32 (50.0%)

Trials by Status

recruiting125%
completed375%

Recent Activity

1 active trials
Showing 4 of 4
recruitingphase_2

Study of Organ Perfusion in Heart Transplantation in Children

NCT06032195
completedphase_3

Study of Organ Perfusion With Custodiol-N Solution Compared With Custodiol Solution in Heart Transplantation

NCT02869022
completedphase_3

Phase III Study Comparing Two Methods of Cardioplegia in Aortic Valve Surgery Custodiol-N Versus Custodiol

NCT02098772
completedphase_2

Phase III Study Comparing Two Methods of Cardioplegia in Coronary Artery Bypass Surgery

NCT01444235

Clinical Trials (4)

Showing 4 of 4 trials
NCT06032195Phase 2

Study of Organ Perfusion in Heart Transplantation in Children

Recruiting
NCT02869022Phase 3

Study of Organ Perfusion With Custodiol-N Solution Compared With Custodiol Solution in Heart Transplantation

Completed
NCT02098772Phase 3

Phase III Study Comparing Two Methods of Cardioplegia in Aortic Valve Surgery Custodiol-N Versus Custodiol

Completed
NCT01444235Phase 2

Phase III Study Comparing Two Methods of Cardioplegia in Coronary Artery Bypass Surgery

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4